WILKES-BARRE, LUZERNE COUNTY (WBRE/WYOU) — October is Breast Cancer Awareness Month, and the state’s Department of Health made a stop in Wilkes-Barre on Monday to take a closer look at new breast ...

A new CRISPR-powered light sensor can detect the faintest whispers of cancer in a single drop of blood.

According to the American Cancer Society, lung cancer is the deadliest cancer in the United States and the second most common type of cancer. A promising new approach could change that: advanced ...

PORTSMOUTH — Portsmouth Regional Hospital, part of HCA Healthcare, recently provided staff, physicians and the public with the opportunity to explore the latest advancements in the diagnosis and ...

Technology created at the University of Queensland could improve the odds of surviving brain cancer and change how we treat a ...

A Chicago doctor is using new FDA-approved technology that makes cancer cells glow during surgery. Here's how it works.

Cancer detection and treatment research will receive up to $115 million for three projects funded under agreements between the Advanced Research Projects Agency for Health (ARPA-H) and Rice University ...

PHOENIX - New technology is improving the way Breast Cancer surgery is done. "We wanted to get away from the wired technology, and that's where the industry has moved now to what we call ‘wireless ...

Pre-clinical modeling, often using laboratory mice, is essential in developing life-saving therapies to treat cancer and other diseases. While mouse models remain a necessary component in ...

Evolving Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Hormone-Sensitive Prostate Cancer: More Questions than Answers? It is also noteworthy that patients can ...

Breakthroughs, discoveries, and DIY tips sent six days a week. Terms of Service and Privacy Policy. Ozone is like Earth’s natural sunscreen, protecting living ...

Electronic nose (e-nose) technology identified early-stage lung cancer with high reliability in a prospective observational clinical trial conducted at Memorial Sloan Kettering Cancer Center (MSK).